Population and Public Health
GE Research has received a grant from the NIH to develop sensors that can be embedded into mobile devices to detect COVID-19 particles on their surfaces.
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution.
System which identifies patients at risk of fatal heart attack obtains CE mark.
Hayat-Vax is a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42. Meanwhile, the country’s COVID-19 contact tracing app will now also function as a national vaccine registry.
Private bookings for a COVID-19 vaccine start from AED 1,300 (approx. $354).
According to FDA documents, the test is intended to help stop the spread of COVID-19 among Amazon employees.
Since January 2021, all 72 million statutorily insured German citizens have been legally entitled to a national electronic patient record (ePA).
PWNHealth will rebrand as Everly Health Solutions and will operate as an independent arm of Everly Health.
The pilot study in north-east England will pioneer a personalised medicine approach.